Decode the Impact of SARS-CoV-2 on Human Pancreas
解读 SARS-CoV-2 对人类胰腺的影响
基本信息
- 批准号:10319780
- 负责人:
- 金额:$ 44.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-05 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVACE2Acinar CellAlpha CellAutopsyBeta CellBlood VesselsCOVID-19COVID-19 detectionCOVID-19 mortalityCOVID-19 pandemicCOVID-19 patientCOVID-19 susceptibilityCell physiologyCellsCellular Stress ResponseCessation of lifeClinicalClinical DataClinical ResearchCytokine SignalingCytometryDataDefectDevelopmentDiabetes MellitusDiseaseDuctal Epithelial CellEndocrineEndothelial CellsEukaryotic Initiation Factor-2EventFunctional disorderGlucagonHumanImageImpairmentIndividualInfectionInflammationInsulinInsulin ResistanceInsulin-Dependent Diabetes MellitusIslet CellIslets of LangerhansLaboratoriesMetabolicModelingMorbid ObesityNRP1 geneNon-Insulin-Dependent Diabetes MellitusOrganoidsOutcomePancreasPancreatic ductParacrine CommunicationPathogenesisPathologicPathologyPathway interactionsPatientsPhenotypePlayPublishingResearch PersonnelRisk FactorsRoleSARS-CoV-2 infectionSamplingSignal TransductionSpecimenStructure of beta Cell of isletTechnologyTestingTherapeuticTissuesTumor-infiltrating immune cellsVirusautoimmune pathogenesisbasechemokinecoronavirus diseasehigh riskimaging systemisletmacrophagemultidisciplinarynovel therapeuticspandemic diseaseparacrinephysiologic modelsevere COVID-19single-cell RNA sequencingstem cellstransdifferentiation
项目摘要
Abstract.
Recent clinical data has suggested a bidirectional interaction between Coronavirus disease 19 (COVID-19) and
diabetes.
Individuals with diabetes and severe obesity are more likely to be
complications, and have a higher COVID-19
mortality rate
symptomatic
. Conversely, new-onset diabetes and severe
, are at a higher risk for
metabolic complications of pre-existing diabetes have been observed in COVID-19 patients. Thus, there is a
strong need to understand the pathology and mechanism of pancreatic dysfunction in COVID-19 patients. Here,
we demonstrate the detection of SARS-CoV-2 in pancreatic endocrine cells in autopsy samples from COVID-19
patients. Single cell RNA-seq and immunostaining confirmed that multiple types of pancreatic islet cells are
susceptible to SARS-CoV-2, eliciting a cellular stress response and the induction of chemokines. Upon SARS-
CoV-2 infection, beta cells show a decreased expression of insulin and the increased expression of alpha and
acinar cell markers, including glucagon and PRSS1/trypsin1, respectively, suggesting cellular
transdifferentiation.
Hyperion technology to examine the pathogenesis of autopsy samples
of COVID-19 patients. In addition, we will use human islets and a vascularized human pancreatic organoid
models to systematically evaluate the role of direct infection and paracrine inflammation signal on human
endocrine cells cellular identities, function and survival.
In the proposal, we will apply state-of-art
Through this study, we would expect to provide a
systematic overview of the pathological changes in the pancreas of COVID-19 patients, as well as a detailed
mechanism to understand endocrine cell dysfunction, which will pave the road to the development of novel
therapy to protect endocrine cell function in COVID-19 patients.
抽象的。
最近的临床数据表明,冠状病毒19(Covid-19)和
糖尿病。
患有糖尿病和严重肥胖的人更有可能
并发症,Covid-19
死亡率
有症状
。相反,新的糖尿病和严重
,面临更高的风险
在Covid-19患者中已经观察到已经存在的糖尿病的代谢并发症。因此,有一个
强烈需要了解Covid-19患者胰腺功能障碍的病理和机制。这里,
我们证明了来自Covid-19
患者。单细胞RNA-seq和免疫染色证实了多种类型的胰岛细胞是
易受SARS-COV-2的影响,引起细胞应激反应和趋化因子的诱导。在sars上 -
COV-2感染,β细胞显示胰岛素表达降低,并且α和
腺泡细胞标记,包括胰高血糖素和PRSS1/胰蛋白酶1,表明细胞
转变。
Hyperion技术检查尸检样品的发病机理
Covid-19患者。此外,我们将使用人类胰岛和血管化的人类胰腺器官
系统地评估直接感染和旁分泌炎症信号对人的作用的模型
内分泌细胞的细胞身份,功能和存活。
在提案中,我们将应用最新
通过这项研究,我们希望提供
系统概述Covid-19患者胰腺的病理变化,以及详细的
了解内分泌细胞功能障碍的机制,这将为新颖的发展铺平道路
治疗可保护COVID-19患者的内分泌细胞功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shuibing Chen其他文献
Shuibing Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shuibing Chen', 18)}}的其他基金
Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression
来自人类胰岛的异常细胞外囊泡和颗粒影响 T1D 进展
- 批准号:
10754074 - 财政年份:2023
- 资助金额:
$ 44.01万 - 项目类别:
Decode the Impact of SARS-CoV-2 on Human Pancreas
解读 SARS-CoV-2 对人类胰腺的影响
- 批准号:
10646228 - 财政年份:2021
- 资助金额:
$ 44.01万 - 项目类别:
Decode the Impact of SARS-CoV-2 on Human Pancreas
解读 SARS-CoV-2 对人类胰腺的影响
- 批准号:
10443871 - 财政年份:2021
- 资助金额:
$ 44.01万 - 项目类别:
A High Content Chemical Screen to Identify the Drug Candidates Promoting Human Beta Cell Proliferation
用于鉴定促进人类β细胞增殖的候选药物的高内涵化学筛选
- 批准号:
10343755 - 财政年份:2020
- 资助金额:
$ 44.01万 - 项目类别:
A High Content Chemical Screen to Identify the Drug Candidates Promoting Human Beta Cell Proliferation
用于鉴定促进人类β细胞增殖的候选药物的高内涵化学筛选
- 批准号:
10571823 - 财政年份:2020
- 资助金额:
$ 44.01万 - 项目类别:
A High Content Chemical Screen to Identify the Drug Candidates Promoting Human Beta Cell Proliferation
用于鉴定促进人类β细胞增殖的候选药物的高内涵化学筛选
- 批准号:
10117247 - 财政年份:2020
- 资助金额:
$ 44.01万 - 项目类别:
Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression
确定导致早期 T1D 进展的内在信号和环境信号
- 批准号:
10262967 - 财政年份:2020
- 资助金额:
$ 44.01万 - 项目类别:
Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression
确定导致早期 T1D 进展的内在信号和环境信号
- 批准号:
10440517 - 财政年份:2020
- 资助金额:
$ 44.01万 - 项目类别:
Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression
确定导致早期 T1D 进展的内在信号和环境信号
- 批准号:
10157473 - 财政年份:2020
- 资助金额:
$ 44.01万 - 项目类别:
Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression
确定导致早期 T1D 进展的内在信号和环境信号
- 批准号:
10653103 - 财政年份:2020
- 资助金额:
$ 44.01万 - 项目类别:
相似国自然基金
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
- 批准号:82373169
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
- 批准号:82330111
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
- 批准号:32300137
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
- 批准号:82305216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
- 批准号:32302080
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections
SARS-CoV-2介导的唾液腺功能障碍对分泌的唾液抗菌肽的影响以及口腔机会性感染的风险
- 批准号:
10429036 - 财政年份:2022
- 资助金额:
$ 44.01万 - 项目类别:
Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections
SARS-CoV-2介导的唾液腺功能障碍对分泌的唾液抗菌肽的影响以及口腔机会性感染的风险
- 批准号:
10594559 - 财政年份:2022
- 资助金额:
$ 44.01万 - 项目类别:
Genetic investigation of SARS-CoV-2 infection in oral and nasal tissues
口腔和鼻腔组织中 SARS-CoV-2 感染的基因研究
- 批准号:
10667249 - 财政年份:2022
- 资助金额:
$ 44.01万 - 项目类别:
Decode the Impact of SARS-CoV-2 on Human Pancreas
解读 SARS-CoV-2 对人类胰腺的影响
- 批准号:
10646228 - 财政年份:2021
- 资助金额:
$ 44.01万 - 项目类别:
Decode the Impact of SARS-CoV-2 on Human Pancreas
解读 SARS-CoV-2 对人类胰腺的影响
- 批准号:
10443871 - 财政年份:2021
- 资助金额:
$ 44.01万 - 项目类别: